2138 — EC Healthcare Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeSmall CapNeutral

Annual income statement for EC Healthcare, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,920	3,875	4,211	4,140	3,770
Cost of Revenue
Gross Profit	2,570	3,322	3,545	3,342	2,952
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,549	3,688	4,099	4,056	4,117
Operating Profit	371	187	112	83.7	-347
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	321	136	16.9	-101	-410
Provision for Income Taxes
Net Income After Taxes	271	107	15.7	-112	-413
Minority Interest
Net Income Before Extraordinary Items
Net Income	198	69.7	-18.9	-167	-403
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	198	69.7	-18.9	-167	-403
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.153	0.027	-0.016	-0.219	-0.164
Dividends per Share